Biosign to introduce UFIT at an International Engineering Conference

TORONTO, May 27, 2011 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) ("Biosign") announced today that it will introduce its latest generation medical measurement system, the UFIT® TEN-20, at the International Symposium on Medical Measurements and Applications (MeMeA), being held in Italy by the Institute of Electrical and Electronics Engineers (IEEE) on May 30-31, 2011. Dr Radu Leca, Biosign's CEO, will speak and demonstrate the system during the Plenary Session - Invited Lecture "Issues in Medical Measurement". For further details on the conference, please visit

Biosign's UFIT® TEN-20 is an online medical system for blood pressure and blood glucose monitoring. The device measures the pulse at the wrist through an inflatable cuff and immediately produces blood pressure and blood glucose measurement results. All measurements are indirect, noninvasive and passive. The results are stored on Biosign's servers along with the complete test sample. Readings can be viewed by care providers on a secure web portal and/or integrated into a patient's Electronic Health Record. The UFIT® TEN 20 is approved under ISO-13485 for the non-invasive measurement of blood pressure and blood glucose, and it also carries the CE Mark.

"The MeMeA conference offers us a unique opportunity to introduce our technology to professional and academic thought leaders and to gather their support for our work", stated Dr. Radu Leca, Biosign's CEO.

About IEEE

With more than 400,000 members in over 160 countries, IEEE is the world's largest professional association dedicated to advancing technological innovation and excellence for the benefit of humanity. IEEE and its members inspire a global community through IEEE's highly cited publications, conferences, technology standards, and professional and educational activities

About Biosign Technologies Inc.

Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit

Forward-Looking Statements

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Biosign's actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in, Biosign's filings with Canadian securities regulators (

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

SOURCE Biosign Technologies Inc.

For further information:

Biosign Contact Information            
Colley Clarke
Biosign Technologies
Phone: (416) 218-9800 ext. 234
          Alan S. Roemer
The Trout Group
Phone: (646) 378-2945


Organization Profile

Biosign Technologies Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890